Literature DB >> 192918

Genetic studies of the ploidy of Moloney murine leukemia virus.

J A McCarter.   

Abstract

An assay for Moloney murine leukemia virus was developed that made use of the production of morphologically altered foci in nonproducer mouse cells (15F) carrying murine sarcoma virus. Wild-type (wt) virus gave a ratio of titers at 39 degrees C/34degrees C = 1.05 +/- 0.45 (standard deviation;n = 20). A spontaneous, thermosensitive (ts) mutant of Moloney murine leukemia virus, ts3, defective in a late viral function, gave 39 degrees C/34degrees C = 0. A murine cell line (TB) was mixedly infected with ts3 and wt (multiplicities of infection, 7.8:4.3), cloned after infection, and shown to be infected by both viruses. At 34 degrees C it produced wt, ts, and particles of mixed parentage. The heterozygotes (hz) had ratios of assays 39 degrees C/34 degrees C = 0.06 to 0.84 (mean, 0.36). To eliminate possible interference by multiploid particles with determination of the proportions of the three types of particles, the virus produced by the mixedly infected, cloned cell line at 34 degrees C was distributed by velocity sedimentation in a sucrose gradient, and virus was picked from the lightest part of the gradient. The proportions of ts, wt, and hz were 0.27, 0.26, and 0.47. Those particles identified as hz segreated ts, wt, and hz in the proportions 0.24, 0.27, and 0.49, respectively. These values were not significantly different from those predicted from a diploid model of the genome.

Entities:  

Mesh:

Year:  1977        PMID: 192918      PMCID: PMC515680     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  20 in total

1.  Studies on the budding process of a temperature-sensitive mutant of murine leukemia virus with a scanning electron microscope.

Authors:  P K Wong; R MacLeod
Journal:  J Virol       Date:  1975-08       Impact factor: 5.103

2.  Genomic complexities of murine leukemia and sarcoma, reticuloendotheliosis, and visna viruses.

Authors:  K L Beemon; A J Faras; A T Hasse; P H Duesberg; J E Maisel
Journal:  J Virol       Date:  1976-02       Impact factor: 5.103

3.  Structure, subunit composition, and molecular weight of RD-114 RNA.

Authors:  H J Kung; J M Bailey; N Davidson; M O Nicolson; R M McAllister
Journal:  J Virol       Date:  1975-08       Impact factor: 5.103

4.  RD-114, baboon, and woolly monkey viral RNA's compared in size and structure.

Authors:  H J Kung; S Hu; W Bender; J M Bailey; N Davidson; M O Nicolson; R M McAllister
Journal:  Cell       Date:  1976-04       Impact factor: 41.582

5.  Size, subunit composition, and secondary structure of the Friend virus genome.

Authors:  S Dube; H J Kung; W Bender; N Davidson; W Ostertag
Journal:  J Virol       Date:  1976-10       Impact factor: 5.103

6.  Studies of two temperature-sensitive mutants of Moloney murine leukemia virus.

Authors:  P K Wong; J A McCarter
Journal:  Virology       Date:  1974-04       Impact factor: 3.616

7.  Properties of mouse leukemia viruses. 3. Electron microscopic appearance as revealed after conventional preparation techniques as well as freeze-drying and freeze-etching.

Authors:  M V Nermut; H Frank; W Schäfer
Journal:  Virology       Date:  1972-08       Impact factor: 3.616

8.  DEAE-dextran: enhancement of cellular transformation induced by avian sarcoma viruses.

Authors:  P K Vogt
Journal:  Virology       Date:  1967-09       Impact factor: 3.616

9.  Mixed culture cytopathogenicity: a new test for growth of murine leukemia viruses in tissue culture.

Authors:  V Klement; W P Rowe; J W Hartley; W E Pugh
Journal:  Proc Natl Acad Sci U S A       Date:  1969-07       Impact factor: 11.205

10.  Physical properties of moloney murine leukemia virus high-molecular-weight RNA: a two subunit structure.

Authors:  C H Riggin; M Bondurant; W M Mitchell
Journal:  J Virol       Date:  1975-12       Impact factor: 5.103

View more
  9 in total

1.  Site-directed mutagenesis of the codon for Ile-25 in gPr80env alters the neurovirulence of ts1, a mutant of Moloney murine leukemia virus TB.

Authors:  P F Szurek; E Floyd; P H Yuen; P K Wong
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

2.  Mechanism of murine leukemia virus-induced fusion in rat myoblasts defective in differentiation.

Authors:  P K Wong; P H Yuen; S J Kaufman
Journal:  J Virol       Date:  1977-09       Impact factor: 5.103

3.  In situ hybridization: general infectivity assay for retroviruses.

Authors:  A Rein; N Rice; S Simek; M Cohen; R J Mural
Journal:  J Virol       Date:  1982-09       Impact factor: 5.103

4.  Preliminary characterization of a temperature-sensitive mutant of Moloney murine leukemia virus that produces particles at the restrictive temperature.

Authors:  P K Wong; G E Gallick
Journal:  J Virol       Date:  1978-01       Impact factor: 5.103

5.  Differences in pathogenicity among cloned sublines of a murine leukemia virus.

Authors:  K F Manly; R F Buffett
Journal:  J Virol       Date:  1979-04       Impact factor: 5.103

6.  src Genes of ten Rous sarcoma virus strains, including two reportedly transduced from the cell, are completely allelic; putative markers of transduction are not detected.

Authors:  W H Lee; M Nunn; P H Duesberg
Journal:  J Virol       Date:  1981-09       Impact factor: 5.103

7.  Origin of the minor glycoproteins of murine leukemia viruses.

Authors:  M C Kemp; K S Wise; L E Edlund; R T Acton; R W Compans
Journal:  J Virol       Date:  1978-10       Impact factor: 5.103

8.  Sub-genomic RNA in Moloney leukemia virus grown in lymphoid-derived cell lines consists primarily of homologous viral RNA.

Authors:  J K Ball; G A Dekaban; S M Loosmore; S K Chan; J A McCarter
Journal:  Nucleic Acids Res       Date:  1979-10-25       Impact factor: 16.971

9.  Effects of antibiotic treatment on microbiota, viral transmission and viral pathogenesis of MoMuLV ts1 infected BALB/c mice.

Authors:  Henry Okonta; Xi Cheng; Ritu Chakravarti; Joan Duggan
Journal:  PLoS One       Date:  2022-01-21       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.